FDA’s Gottlieb Adds Confusion to Aimmune’s Claims of Shutdown Delay

Submitted by admin on January 18, 2019 - 12:01am

Source:

Xconomy

News Tags:

Aimmune Therapeutics

FDA

Scott Gottlieb

government shutdown

Headline:

FDA’s Gottlieb Adds Confusion to Aimmune’s Claims of Shutdown Delay

snippet:

The first biotech company to cite the partial government shutdown as a reason for serious delay was Aimmune Therapeutics (NASDAQ: AIMT), as Xconomy reported Tuesday. The announcement, however, soon raised more questions than answers.

Search form

You are here

FDA’s Gottlieb Adds Confusion to Aimmune’s Claims of Shutdown Delay

FDA’s Gottlieb Adds Confusion to Aimmune’s Claims of Shutdown Delay